Legg-Calvé-Perthes Disease in Yorkshire Terriers — Complete Guide
Overview
Legg-Calvé-Perthes disease (LCPD), also called avascular or aseptic necrosis of the femoral head, is one of the most significant orthopedic conditions affecting Yorkshire Terriers and ranks among the breed's top hereditary health concerns. The disease occurs when the blood supply to the femoral head — the ball portion of the hip joint — is disrupted, causing the bone to deteriorate, collapse, and fragment, resulting in progressive pain and hindlimb lameness. Yorkshire Terriers are disproportionately affected compared to dogs in general, with breed-specific incidence estimated at 10–15 times that of the broader canine population. Early recognition and timely surgical intervention typically produce excellent outcomes, with the majority of treated Yorkshire Terriers returning to full, pain-free mobility.
Why Yorkshire Terriers Are Susceptible to Legg-Calvé-Perthes Disease
The Yorkshire Terrier's vulnerability to Legg-Calvé-Perthes disease stems from a combination of genetic inheritance, vascular anatomy, and the biomechanical consequences of miniaturization.
Genetic predisposition. LCPD in Yorkshire Terriers follows an autosomal recessive inheritance pattern, meaning a puppy must inherit a defective copy of the associated gene from both parents to develop the disease. Research has identified a significant locus on canine chromosome 6 linked to LCPD susceptibility in toy breeds. Yorkshire Terriers have one of the highest carrier frequencies among all breeds, which explains the condition's persistent prevalence despite decades of awareness. Because carriers show no outward signs of disease, they unknowingly perpetuate the trait through breeding programs that lack genetic screening. Femoral head vascular anatomy. The blood supply to the developing femoral head in toy breeds relies on a small number of retinacular vessels that course along the femoral neck beneath a thin layer of periosteum. In Yorkshire Terriers, these vessels appear to be particularly vulnerable to compression, kinking, or thrombosis during the rapid growth phase. Unlike larger breeds with more robust collateral blood supply to the femoral head, the Yorkshire Terrier's miniaturized hip vasculature provides little redundancy — a single vascular insult can be enough to initiate ischemic necrosis. Miniaturization and skeletal architecture. Selective breeding for very small body size has produced femoral heads and necks of extremely small dimensions. The proportionally thin cortical bone and the narrow nutrient channels in these tiny structures amplify the consequences of any circulatory compromise. The mechanical loads relative to tissue cross-sectional area may also be higher in very active toy breeds, contributing to microdamage that exacerbates the ischemic process. Breed prevalence. Yorkshire Terriers consistently appear among the top three breeds affected by LCPD in veterinary orthopedic literature, alongside Miniature Pinschers and West Highland White Terriers. Orthopedic referral hospital data suggest that Yorkshire Terriers account for 15–20% of all LCPD cases despite representing a much smaller share of the overall dog population. OFA hip evaluation data for the breed reflect a higher-than-average rate of abnormal findings attributable to femoral head pathology.Recognizing Legg-Calvé-Perthes Disease in Your Yorkshire Terrier
LCPD develops gradually, and Yorkshire Terriers often compensate remarkably well in the early stages, which can delay owner recognition.
Progressive hindlimb lameness. The earliest and most consistent sign is a gradually worsening limp on one rear leg. In Yorkshire Terriers, this often begins as subtle — a slight shortening of stride, a mild head bob, or a preference for carrying more weight on the opposite hind leg. Unlike patellar luxation, which tends to produce an intermittent skip, LCPD lameness is typically persistent and progressive over weeks to months. Pain on hip manipulation. Gently extending and rotating the affected hip triggers a pain response — your Yorkie may flinch, cry out, snap, or attempt to pull away. This is one of the most reliable distinguishing features of LCPD and is readily elicited during veterinary examination. The pain worsens as the femoral head undergoes progressive collapse and fragmentation. Muscle wasting. The thigh and gluteal muscles on the affected side visibly shrink as the dog avoids full weight-bearing. In a small dog like the Yorkshire Terrier, this asymmetry can become noticeable within two to four weeks of onset. Running your hands over both hind limbs and comparing muscle fullness is a simple at-home check. Reluctance to play, jump, or climb. A previously active Yorkie may begin hesitating before jumping onto furniture, refuse to run during play, or show a marked decrease in overall energy. Because Yorkshire Terriers are frequently carried by their owners, reduced spontaneous activity may be attributed to personality rather than pain. Irritability when handled around the hindquarters. Dogs in pain may growl, stiffen, or move away when touched near the hip or thigh. A Yorkshire Terrier that suddenly objects to being picked up — particularly when hands are placed around the pelvic area — should be evaluated for hip pathology. Audible crepitus. In advanced cases where the femoral head has partially collapsed or fragmented, a grinding or clicking sensation may be felt or heard when the hip is moved through its range of motion.Age of Onset in Yorkshire Terriers
Legg-Calvé-Perthes disease has a well-defined developmental window that is remarkably consistent across affected Yorkshire Terriers.
4 to 8 months: This is the primary window of disease onset. The ischemic insult to the femoral head occurs during the period of rapid skeletal growth. Clinical signs most commonly appear between 5 and 8 months of age, though the underlying vascular disruption may begin weeks before external signs are evident. Owners should be particularly vigilant for any hindlimb lameness during this critical growth phase. 8 to 12 months: Yorkshire Terriers that develop LCPD later in the typical window often present between 8 and 12 months. By this stage, radiographic changes are usually well established, with visible femoral head irregularity, flattening, or fragmentation. Dogs presenting at this age may already have moderate muscle atrophy and significant hip pain. Under 4 months: Onset before 4 months is uncommon but documented. Very early-onset cases can be challenging to diagnose because the immature skeleton may not yet show clear radiographic changes, and lameness in very young puppies can be attributed to other causes. Over 12 months: True LCPD rarely presents for the first time after 12 months of age. However, dogs with mild or subclinical disease may not come to clinical attention until secondary degenerative joint disease produces symptoms in young adulthood. If a Yorkshire Terrier over one year old develops progressive hip lameness, the differential diagnosis should include LCPD with late presentation alongside other hip pathologies. Bilateral involvement: Approximately 10–15% of affected Yorkshire Terriers develop LCPD in both hips, though one side is usually more severely affected. The second hip may become symptomatic weeks to months after the first, so continued monitoring of both hips is important after an initial diagnosis.Diagnostic Process
Orthopedic examination. The veterinarian will assess gait, palpate for muscle asymmetry, and perform range-of-motion testing of both hips. In LCPD, pain is typically most pronounced on extension and internal rotation of the affected hip. Decreased range of motion compared to the opposite hip is common. Crepitus may be detected in advanced cases. Radiography. Hip radiographs are the cornerstone of LCPD diagnosis. Characteristic findings progress through recognizable stages: early loss of density in the femoral head epiphysis; subchondral lucencies (dark lines within the bone); femoral head flattening, irregularity, and fragmentation; widening of the joint space; and eventually femoral neck shortening with secondary acetabular changes. Given the Yorkshire Terrier's tiny skeletal dimensions, high-resolution digital radiography and precise positioning (under sedation) are essential for diagnostic accuracy. Ventrodorsal hip-extended and frog-leg lateral views are standard. CT imaging. Computed tomography can reveal early-stage LCPD changes before they become apparent on standard radiographs and provides detailed three-dimensional assessment of femoral head integrity. CT is most valuable in equivocal cases or for surgical planning when the extent of femoral head involvement needs precise characterization. Differential diagnosis. In a young Yorkshire Terrier with hindlimb lameness, the primary differential for LCPD is patellar luxation — the two conditions can coexist in the same dog. Fracture of the femoral capital physis, septic arthritis, and hip dysplasia (uncommon in toy breeds) should also be considered. The clinical combination of hip-specific pain, progressive lameness in a puppy aged 4–12 months, and characteristic radiographic findings is highly diagnostic. Genetic screening. DNA testing for LCPD susceptibility is available through some commercial canine genetic testing platforms. While the genetic architecture is not fully mapped, current tests can identify dogs at elevated risk based on known associated markers. This information is particularly valuable for breeding decisions but does not replace clinical and radiographic evaluation for diagnosis in symptomatic dogs.Treatment Approach for Yorkshire Terriers
Conservative Management
Conservative treatment — rest, anti-inflammatory medication, and restricted activity — may temporarily reduce pain but does not address the underlying bone destruction. LCPD is a structural disease: the femoral head is physically collapsing. Conservative management is generally reserved only for very mild cases discovered incidentally or as a bridge to surgery in dogs that are not yet surgical candidates.
Anti-inflammatory medication. Veterinary NSAIDs (meloxicam or carprofen in precise liquid formulations appropriate for toy-breed dosing) can reduce joint inflammation and provide short-term comfort. In Yorkshire Terriers, liquid oral formulations are strongly preferred over tablets to avoid dosing errors — at body weights of 4 to 7 pounds, small measurement errors produce large percentage deviations from the target dose.Surgical Treatment — Femoral Head and Neck Ostectomy (FHO)
FHO is the standard-of-care surgical treatment for LCPD in Yorkshire Terriers and carries an excellent prognosis in this breed.
The procedure. FHO involves surgical removal of the damaged femoral head and neck. The body forms a "false joint" (pseudoarthrosis) of fibrous tissue between the remaining femur and the acetabulum. While this sounds radical, the outcome in small, lightweight dogs like Yorkshire Terriers is typically outstanding — the fibrous joint provides a functional, pain-free articulation that supports the dog's light frame. Why FHO works particularly well in Yorkshire Terriers. Body weight is the single strongest predictor of FHO outcome. At 4 to 7 pounds, Yorkshire Terriers fall well within the weight range where the pseudoarthrosis reliably achieves excellent load-bearing capacity. Studies consistently report that over 90% of toy-breed dogs treated with FHO return to normal or near-normal function. The low body mass also means the fibrous joint bears minimal stress during daily activities, contributing to durable long-term results. Total hip replacement (THR). Micro total hip replacement systems designed for dogs under 10 pounds exist and can restore native hip biomechanics. However, FHO remains the far more common choice for Yorkshire Terriers because outcomes are excellent, the procedure is less technically demanding, and it avoids the risks associated with prosthetic implants in very small bones. THR may be considered in cases of bilateral disease or in performance or working dogs where maximal hip function is desired. Anesthesia considerations. Yorkshire Terriers require breed-aware anesthesia protocols. Their high surface-area-to-mass ratio predisposes them to rapid hypothermia — active warming with forced-air blankets and heated fluid lines is mandatory throughout surgery. Perioperative hypoglycemia is a recognized risk, particularly in young puppies undergoing prolonged procedures, necessitating blood glucose monitoring and intravenous dextrose supplementation. Tiny peripheral veins require skilled IV catheter placement. Pre-anesthetic bloodwork should include a complete metabolic panel, with particular attention to liver function given the breed's predisposition to portosystemic shunts that can affect drug metabolism. Pain management. Post-operative analgesia typically combines a veterinary NSAID with gabapentin (starting at approximately 5 mg/kg every 8–12 hours, adjusted for sedation) or tramadol. Doses must be calculated precisely using the dog's actual body weight measured on a gram-accurate scale. Yorkshire Terriers do not carry the MDR1 mutation, so standard analgesic drugs are appropriate, but their small body mass demands meticulous dosing. Recovery expectations. Most Yorkshire Terriers begin toe-touching weight-bearing within 1 to 2 weeks of FHO surgery. Progressive improvement continues over 6 to 12 weeks, with most dogs achieving full functional recovery by 8 to 16 weeks. Formal physical rehabilitation — including passive range-of-motion exercises, controlled leash walks, and hydrotherapy — accelerates recovery and promotes formation of a robust pseudoarthrosis. Full return to normal activity, including running and playing, is expected.Managing Legg-Calvé-Perthes Disease Day-to-Day
Post-surgical rehabilitation. Physical therapy is the single most important factor in optimizing FHO outcomes. Passive range-of-motion exercises (gently flexing and extending the hip through its comfortable arc, 10–15 repetitions, three to four times daily) should begin within days of surgery. Warm compresses applied for 5 minutes before therapy sessions reduce stiffness. As weight-bearing improves, controlled leash walks of gradually increasing duration build muscle and encourage use of the operated limb. Hydrotherapy. Swimming or underwater treadmill sessions provide ideal non-weight-bearing exercise that strengthens the hip musculature without impact stress. Many canine rehabilitation facilities offer toy-breed-appropriate hydrotherapy programs. Even supervised shallow-water wading in a bathtub can be beneficial in the early recovery weeks. Exercise modifications. During recovery, all high-impact activities — jumping on or off furniture, running on hard surfaces, rough play — must be eliminated. Pet ramps or steps to beds and sofas prevent re-injury. After full recovery, most Yorkshire Terriers with successful FHO can return to normal activity levels without permanent restrictions, though providing ramps and avoiding excessive jumping remains prudent for long-term joint health. Environmental adaptations. Non-slip flooring (rugs, yoga mats, or anti-slip paw wax on tile and hardwood) prevents the hind legs from splaying during recovery. An orthopedic memory-foam bed with low sides provides comfortable, joint-supportive rest without requiring the dog to jump in or out. Nutrition and weight management. Maintaining a lean body condition (body condition score 4–5 on the 9-point scale) is critical both during recovery and long-term. Excess weight directly increases mechanical stress on the reconstructed hip. Weigh your Yorkshire Terrier monthly on a kitchen or gram scale — bathroom scales lack sufficient resolution at this body weight. Feed a measured, high-quality diet formulated for toy breeds. Supplements. Omega-3 fatty acids (EPA/DHA from marine sources, approximately 75–100 mg combined per 10 pounds of body weight daily) support anti-inflammatory pathways. Glucosamine-chondroitin and green-lipped mussel extract may provide additional joint support. Choose formulations designed for small dogs with appropriately concentrated dosing.Breeder Screening & Prevention
Reducing LCPD prevalence in Yorkshire Terriers requires disciplined screening and breeding practices.
Radiographic hip evaluation. All Yorkshire Terriers intended for breeding should undergo hip radiographs evaluated by a veterinary radiologist or submitted to the OFA for formal assessment. Radiographs should be performed at 12 months of age or older, ideally under sedation for diagnostic-quality positioning. Only dogs with normal femoral head architecture on radiography should be used for breeding. DNA testing. Genetic tests that identify markers associated with LCPD susceptibility are available through commercial platforms such as Embark. While no single-gene test is fully predictive, these panels provide valuable risk information. Breeding two carriers together produces a 25% chance of affected offspring under an autosomal recessive model. Ideally, at least one parent in every mating should test clear of known LCPD-associated risk markers. Pedigree analysis. Breeders should maintain detailed health records across generations and track LCPD occurrence in siblings, half-siblings, and offspring of breeding dogs. Two radiographically normal parents that each carry affected relatives still present meaningful risk of producing affected puppies. Depth of pedigree health data — spanning at least three generations — provides substantially more predictive power than parental status alone. Combined orthopedic screening. Because Yorkshire Terriers are predisposed to both LCPD and patellar luxation, a comprehensive pre-breeding orthopedic workup should include both hip radiographs and formal patellar evaluation. The YTCA recommends this dual screening as part of its breed health testing protocol. Buyer guidance. Prospective Yorkshire Terrier owners should ask breeders for OFA hip evaluation results, genetic test results for LCPD risk markers, and health histories of related dogs. Breeders who openly share both normal and abnormal results and who actively track orthopedic outcomes across their lines demonstrate genuine commitment to reducing LCPD in the breed. Avoid breeders who dismiss LCPD as "not a problem in my line" without testing data to support the claim.Support & Resources
- Yorkshire Terrier Club of America (YTCA) — The AKC parent club for the breed, providing health resources, recommended health testing protocols, and breeder referrals. [ytca.org](https://ytca.org)
- Orthopedic Foundation for Animals (OFA) — Public database for verifying hip evaluations, patellar luxation grades, and other health certifications for individual dogs and breed-wide statistics. [ofa.org](https://ofa.org)
- American College of Veterinary Surgeons (ACVS) — Directory of board-certified veterinary surgeons experienced in FHO and toy-breed orthopedic procedures. [acvs.org](https://acvs.org)
- Canine Rehabilitation Institute (CRI) — Find certified canine rehabilitation practitioners with toy-breed orthopedic specialization for post-surgical physical therapy.
- Yorkshire Terrier National Rescue (YTNR) — Health guidance and support for adopted Yorkies, including those diagnosed with LCPD.
- Embark Veterinary — Commercial canine genetic testing with LCPD-associated marker screening. [embarkvet.com](https://embarkvet.com)
- Online communities — Breed-specific groups such as Yorkshire Terrier Health & Wellness on Facebook and dedicated Yorkie forums provide peer support from owners who have navigated LCPD diagnosis, surgery, and recovery.